Drag a card by its title · ⚙ to size, swap or remove

The company

Bausch + Lomb Corporation Common Shares

BLCO · NYSE

Health CareMedical DevicesAbove a falling average

BLCO stood above a rising 150-day average in 27 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 1.2% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

SEC filings

Statistics

Rotation: Above a falling average
Weeks in an uptrend: out for 3
Industry in uptrend: 27% -7 in 4 wk
Insider buys, 12 months: $2.4M
Insider sales, 12 months: $2.4M
Officials’ trades on record: 0
Institutions holding: 94 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 27 of 52 weeks.

20 Apr – 19 Oct

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months9

Sale orders, 12 months3

Buyers · sellers9 · 2

Who	Did	Shares	Traded
Frederick MunschSVP, Controller and CAO	sold	52,900at $16.78	10 Aug 2026filed 12 Aug 2026
Eschenbach Andrew C. VonDirector	sold	6,059at $16.58	7 Aug 2026filed 10 Aug 2026
Eschenbach Andrew C. VonDirector	sold	12,500at $16.50	6 Aug 2026filed 10 Aug 2026
Brent L. SaundersCEO and Chairman of the Board	bought	14,700at $17.14	6 Mar 2026filed 10 Mar 2026
Sam EldessoukyEVP and CFO	bought	4,000at $17.13	6 Mar 2026filed 10 Mar 2026
A. Robert D. BaileyEVP & Chief Legal Officer	bought	14,600at $17.15	6 Mar 2026filed 10 Mar 2026
Thomas W. Ross, Sr.Director	bought	4,500at $17.68	3 Mar 2026filed 4 Mar 2026
Eduardo AlfonsoDirector	bought	4,300at $17.90	2 Mar 2026filed 3 Mar 2026
Eschenbach Andrew C. VonDirector	bought	4,364at $18.31	27 Feb 2026filed 3 Mar 2026
Steven H. CollisDirector	bought	15,000at $17.81	23 Feb 2026filed 24 Feb 2026
Russel C. RobertsonDirector	bought	4,400at $17.90	20 Feb 2026filed 24 Feb 2026
Karen LingDirector	bought	4,000at $17.74	19 Feb 2026filed 23 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders94+3 on the quarter

New · exited20 · 17

Reported value$592.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
ICAHN CARL Cunchanged · filed 14 Aug 2026	3,500,000$58.0M	00.0%
OAKTREE CAPITAL MANAGEMENT LPadded · filed 14 Aug 2026	3,441,042$57.0M	+58,303+1.7%
DEUTSCHE BANK AG\reduced · filed 7 Aug 2026	3,423,046$56.7M	-105,395−3.0%
D. E. Shaw & Co., Inc.added · filed 14 Aug 2026	3,323,021$55.0M	+171,854+5.5%
Davidson Kempner Capital Management LPadded · filed 14 Aug 2026	3,158,972$52.3M	+959,800+43.6%
GOLDENTREE ASSET MANAGEMENT LPunchanged · filed 14 Aug 2026	2,660,508$44.0M	00.0%
CASPIAN CAPITAL LPunchanged · filed 14 Aug 2026	1,999,043$33.1M	00.0%
GLENVIEW CAPITAL MANAGEMENT, LLCadded · filed 14 Aug 2026	1,918,148$31.8M	+7,652+0.4%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPadded · filed 13 Aug 2026	1,364,980$22.6M	+382,918+39.0%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026	987,730$16.4M	+282,509+40.1%